Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.63B
Enterprise Value12.52B
P/E Ratio21.51
PEG Ratio0.72
Price/Sales Ratio1.5
Price/Book Ratio1.68
Enterprise/Revenue1.46
Enterprise/EBITDA8.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue10.55B
Revenue/Share8.98
Gross Profit4.73B
EBITDA1.89B
Net Income540.71M
Diluted EPS0.46

Balance Sheet

Total Cash1.86B
Total Cash/Share1.62
Total Debt1.44B
Total Debt/Equity0.16
Current Ratio1
Book Value Per Share8.01

Price History

52-Week Change14.64
52-Week High15
52-Week Low9.35
Moving Average 50 Days11.65
Moving Average 200 Days10.81

Statistics

Average Volume40.36M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.21
Trailing Annual Dividend Yield1.61
Payout Ratio0.44
Last Split Factor8:5
Last Split DateMay 25, 2012
AD